135 related articles for article (PubMed ID: 7549823)
1. Influence of anethole treatment on the tumour induced by Ehrlich ascites carcinoma cells in paw of Swiss albino mice.
al-Harbi MM; Qureshi S; Raza M; Ahmed MM; Giangreco AB; Shah AH
Eur J Cancer Prev; 1995 Aug; 4(4):307-18. PubMed ID: 7549823
[TBL] [Abstract][Full Text] [Related]
2. Studies on the cytotoxic, biochemical and anti-carcinogenic potentials of ninhydrin on Ehrlich ascites carcinoma cell-bearing Swiss albino mice.
Qureshi S; Al-Shabanah OA; Al-Bekairi AM; Al-Harbi MM; Al-Gharably NM; Raza M
Invest New Drugs; 2000 Aug; 18(3):221-30. PubMed ID: 10958590
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the genotoxic, cytotoxic, and antitumor properties of Commiphora molmol using normal and Ehrlich ascites carcinoma cell-bearing Swiss albino mice.
Qureshi S; al-Harbi MM; Ahmed MM; Raza M; Giangreco AB; Shah AH
Cancer Chemother Pharmacol; 1993; 33(2):130-8. PubMed ID: 8261571
[TBL] [Abstract][Full Text] [Related]
4. Anticarcinogenic effect of Commiphora molmol on solid tumors induced by Ehrlich carcinoma cells in mice.
al-Harbi MM; Qureshi S; Raza M; Ahmed MM; Giangreco AB; Shah AH
Chemotherapy; 1994; 40(5):337-47. PubMed ID: 7956458
[TBL] [Abstract][Full Text] [Related]
5. Boric acid enhances in vivo Ehrlich ascites carcinoma cell proliferation in Swiss albino mice.
Qureshi S; Al-Shabanah OA; Al-Harbi MM; Al-Bekairi AM; Raza M
Toxicology; 2001 Aug; 165(1):1-11. PubMed ID: 11551427
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
[TBL] [Abstract][Full Text] [Related]
7. Effect of probucol on the cytological and biochemical changes induced by adriamycin in Swiss albino mice.
al-Gharably NM
Res Commun Mol Pathol Pharmacol; 1996 Dec; 94(3):289-303. PubMed ID: 9029675
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic activities of MT81 and its structural analogue in Ehrlich ascites carcinoma-bearing Swiss Albino mice.
Choudhury SM; Gupta M; Majumder UK
Oxid Med Cell Longev; 2010; 3(1):61-70. PubMed ID: 20716929
[TBL] [Abstract][Full Text] [Related]
9. A new antitumour substance, 7-oxabicyclo (2.2.1)-5-heptene-2,3-dicarboxylic anhydride.
Shimi IR; Zaki Z; Shoukry S; Medhat AM
Eur J Cancer Clin Oncol; 1982 Aug; 18(8):785-93. PubMed ID: 6891327
[TBL] [Abstract][Full Text] [Related]
10. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
11. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
12. Antitumoral effect of a selective Rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in mice.
Isler D; Ozaslan M; Karagoz ID; Kilic IH; Karakok M; Taysi S; Guler I; Cakmak A; Demiryurek AT
Pharmacol Rep; 2014 Feb; 66(1):114-20. PubMed ID: 24905316
[TBL] [Abstract][Full Text] [Related]
13. Studies on the cytological and biochemical effects of valerian in somatic and germ cells of Swiss albino mice.
Al-Majed AA; Al-Yahya AA; Al-Bekairi AM; Al-Shabanah OA; Qureshi S
Food Chem Toxicol; 2006 Nov; 44(11):1830-7. PubMed ID: 16879905
[TBL] [Abstract][Full Text] [Related]
14. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.
Furusawa E; Lum MK; Furusawa S
Chemotherapy; 1981; 27(4):277-86. PubMed ID: 7249790
[TBL] [Abstract][Full Text] [Related]
16. Melatonin effect on the ultrastructure of Ehrlich ascites tumor cells, lifetime and histopathology in Swiss mice.
Batista AP; da Silva TG; Teixeira ÁA; de Medeiros PL; Teixeira VW; Alves LC; dos Santos FA
Life Sci; 2013 Nov; 93(23):882-8. PubMed ID: 24383083
[TBL] [Abstract][Full Text] [Related]
17. The antitumor effect of intraperitoneal treatment with rhTNF-alpha muteins on Ehrlich ascites tumor growth.
Terlikowski S; Nowak HF
Cancer Biother Radiopharm; 2000 Feb; 15(1):39-46. PubMed ID: 10740651
[TBL] [Abstract][Full Text] [Related]
18. Effect of camel urine on the cytological and biochemical changes induced by cyclophosphamide in mice.
al-Harbi MM; Qureshi S; Ahmed MM; Raza M; Baig MZ; Shah AH
J Ethnopharmacol; 1996 Jul; 52(3):129-37. PubMed ID: 8771453
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of silver nanoparticles in Ehrlich carcinoma-bearing mice.
Rageh MM; El-Gebaly RH; Afifi MM
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1421-1430. PubMed ID: 30178417
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
